These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 22825033)
1. Two methods of heterokaryon formation to discover HCV restriction factors. Frentzen A; Hueging K; Bitzegeio J; Pietschmann T; Steinmann E J Vis Exp; 2012 Jul; (65):e4029. PubMed ID: 22825033 [TBL] [Abstract][Full Text] [Related]
2. Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. Frentzen A; Hüging K; Bitzegeio J; Friesland M; Haid S; Gentzsch J; Hoffmann M; Lindemann D; Zimmer G; Zielecki F; Weber F; Steinmann E; Pietschmann T PLoS Pathog; 2011 Apr; 7(4):e1002029. PubMed ID: 21552323 [TBL] [Abstract][Full Text] [Related]
3. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799 [TBL] [Abstract][Full Text] [Related]
4. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells. Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628 [TBL] [Abstract][Full Text] [Related]
5. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles. Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613 [TBL] [Abstract][Full Text] [Related]
6. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication. Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105 [TBL] [Abstract][Full Text] [Related]
7. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281 [TBL] [Abstract][Full Text] [Related]
8. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. Haid S; Windisch MP; Bartenschlager R; Pietschmann T J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758 [TBL] [Abstract][Full Text] [Related]
9. Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction. Marnata C; Saulnier A; Mompelat D; Krey T; Cohen L; Boukadida C; Warter L; Fresquet J; Vasiliauskaite I; Escriou N; Cosset FL; Rey FA; Lanford RE; Karayiannis P; Rose NJ; Lavillette D; Martin A J Virol; 2015 Dec; 89(23):12131-44. PubMed ID: 26401036 [TBL] [Abstract][Full Text] [Related]
10. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773 [TBL] [Abstract][Full Text] [Related]
11. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells. Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection of neuroepithelioma cell lines. Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002 [TBL] [Abstract][Full Text] [Related]
13. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. Bitzegeio J; Bankwitz D; Hueging K; Haid S; Brohm C; Zeisel MB; Herrmann E; Iken M; Ott M; Baumert TF; Pietschmann T PLoS Pathog; 2010 Jul; 6(7):e1000978. PubMed ID: 20617177 [TBL] [Abstract][Full Text] [Related]
14. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. Cai Z; Zhang C; Chang KS; Jiang J; Ahn BC; Wakita T; Liang TJ; Luo G J Virol; 2005 Nov; 79(22):13963-73. PubMed ID: 16254332 [TBL] [Abstract][Full Text] [Related]
15. Replication of a hepatitis C virus replicon clone in mouse cells. Uprichard SL; Chung J; Chisari FV; Wakita T Virol J; 2006 Oct; 3():89. PubMed ID: 17069661 [TBL] [Abstract][Full Text] [Related]
16. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection. Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818 [TBL] [Abstract][Full Text] [Related]
17. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a Tong Y; Chi X; Yang W; Zhong J J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619 [TBL] [Abstract][Full Text] [Related]